Rabbit Anti-Armenian hamster IgG H&L (HRP) (ab5745)
Key features and details
- Rabbit Anti-Armenian hamster IgG H&L (HRP)
- Conjugation: HRP
- Host species: Rabbit
- Isotype: IgG
- Suitable for: Dot blot, WB, ELISA, Electron Microscopy, IHC-P, ICC
製品の概要
-
製品名
Rabbit Anti-Armenian hamster IgG H&L (HRP)
IgG 二次抗体 製品一覧 -
由来種
Rabbit -
ターゲット生物種
Armenian hamster -
特異性
Assay by immunoelectrophoresis resulted in a single precipitin arc against anti-Peroxidase, anti-Rabbit Serum, Armenian Hamster IgG and Armenian Hamster Serum. -
アプリケーション
適用あり: Dot blot, WB, ELISA, Electron Microscopy, IHC-P, ICCmore details -
免疫原
Armenian Hamster IgG whole molecule.
-
標識
HRP
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C. -
バッファー
pH: 6.50
Preservative: 0.01% Gentamicin sulphate
Constituents: 0.42% Tripotassium orthophosphate, 0.87% Sodium chloride, 1% BSA
BSA is IgG and protease free -
Concentration information loading...
-
特記事項(精製)
This product was prepared from monospecific antiserum by immunoaffinity chromatography using Armenian Hamster IgG coupled to agarose. -
特記事項(標識)
Horseradish Peroxidase (HRP). -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG -
研究分野
関連製品
-
Substrate reagent
- TMB ELISA Substrate (Highest Sensitivity) (ab171522)
- TMB ELISA Substrate (High Sensitivity) (ab171523)
- TMB ELISA Substrate (Fast Kinetic Rate) (ab171524)
- TMB ELISA Substrate (Slow Kinetic Rate) (ab171525)
- TMB ELISA Substrate (Slower Kinetic Rate) (ab171526)
- TMB ELISA Substrate (Slowest Kinetic Rate) (ab171527)
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab5745の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
Dot blot |
Use at an assay dependent concentration.
|
|
WB |
1/1000 - 1/5000.
|
|
ELISA |
1/25000. This product has been assayed against 1.0 ug of Armenian Hamster IgG in a standard capture ELISA using ABTS (2,2’-azino-bis-[3-ethylbenthiazoline-6-sulfonic acid]) as a substrate for 30 minutes at room temperature.
|
|
Electron Microscopy |
Use at an assay dependent concentration.
|
|
IHC-P | (1) |
1/1000 - 1/5000.
|
ICC |
1/1000 - 1/5000.
|
特記事項 |
---|
Dot blot
Use at an assay dependent concentration. |
WB
1/1000 - 1/5000. |
ELISA
1/25000. This product has been assayed against 1.0 ug of Armenian Hamster IgG in a standard capture ELISA using ABTS (2,2’-azino-bis-[3-ethylbenthiazoline-6-sulfonic acid]) as a substrate for 30 minutes at room temperature. |
Electron Microscopy
Use at an assay dependent concentration. |
IHC-P
1/1000 - 1/5000. |
ICC
1/1000 - 1/5000. |
画像
-
ab5745 tested against purified Armenian Hamster IgG. Each well was coated in duplicate with 1.0 µg of Armenian Hamster IgG. The starting dilution of antibody was 5µg/ml and the X-axis represents the log10 of a 3-fold dilution. This titration is a 4-parameter curve fit where the IC50 is defined as the titer of the antibody. Assay performed using 3% fish gelatin as blocking buffer and TMB substrate
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
Datasheet download
参考文献 (9)
ab5745 は 9 報の論文で使用されています。
- Morimoto Y et al. Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment. Oncogene 41:3511-3523 (2022). PubMed: 35688945
- Li CG et al. Evodiamine Augments NLRP3 Inflammasome Activation and Anti-bacterial Responses Through Inducing a-Tubulin Acetylation. Front Pharmacol 10:290 (2019). PubMed: 30971927
- Boraschi-Diaz I et al. Collagen type I degradation fragments act through the collagen receptor LAIR-1 to provide a negative feedback for osteoclast formation. Bone 117:23-30 (2018). PubMed: 30217615
- Bouillez A et al. MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer. Oncogene 36:4037-4046 (2017). PubMed: 28288138
- Bouillez A et al. MUC1-C promotes the suppressive immune microenvironment in non-small cell lung cancer. Oncoimmunology 6:e1338998 (2017). PubMed: 28932637
- Sofron A et al. High-resolution analysis of the murine MHC class II immunopeptidome. Eur J Immunol 46:319-28 (2016). PubMed: 26495903
- Bianchi R et al. Mutation of Threonine 34 in Mouse Podoplanin-Fc Reduces CLEC-2 Binding and Toxicity in Vivo While Retaining Anti-lymphangiogenic Activity. J Biol Chem 289:21016-21027 (2014). PubMed: 24907275
- Woessner DW & Lim CS Disrupting BCR-ABL in combination with secondary leukemia-specific pathways in CML cells leads to enhanced apoptosis and decreased proliferation. Mol Pharm 10:270-7 (2013). PubMed: 23211037
- Birjandi SZ et al. Alterations in marginal zone macrophages and marginal zone B cells in old mice. J Immunol 186:3441-51 (2011). PubMed: 21307289